The injectable GLP-1 RAs liraglutide 3 mg once daily and semaglutide 2.4 mg once weekly have both gained a licence for weight loss, alongside lifestyle management, in obese/overweight people without T2D (SmPC, 2023b
Enjoy these in moderation and choose lower-mercury options like salmon, shrimp, or crab when possible
Common Side Effects Mild nausea (most common, usually improves within a few weeks) Diarrhea or constipation due to slowed digestion Bloating or fullness after meals Mild headaches or fatigue Less Common But Serious Side Effects Pancreatitis (rare) Watch for persistent, severe abdominal pain. Hypoglycemia (rare in non-diabetics) Can occur when combined with insulin therapy. Allergic reactions (very rare) Monitor for rash, swelling, or difficulty breathing
These findings don't establish that Wegovy should not be used - the cardiovascular, metabolic, and weight-management benefits are substantial and well-documented
Some wellness centers even advertise them as quick energy boosts
Cohen EP, Lawton CA, Moulder JE, Becker CG, Ash RC
